These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3446541)

  • 1. Botulinum toxin A induced protective ptosis.
    Adams GG; Kirkness CM; Lee JP
    Eye (Lond); 1987; 1 ( Pt 5)():603-8. PubMed ID: 3446541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cornea protection in ptosis induced by botulinum injection].
    Brans JW; Aramideh M; Schlingemann RO; Oen VM; Speelman JD; Ongerboer de Visser BW
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1031-3. PubMed ID: 8684496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified transconjunctival technique for botulinum toxin chemodenervation of levator palpebrae superioris for corneal protection.
    Tint NL; Saxby EPI; Young SL; Alexander P
    Eye (Lond); 2022 Jun; 36(6):1217-1221. PubMed ID: 34117397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary tarsorrhaphy induced with type A botulinum toxin.
    Wuebbolt GE; Drummond G
    Can J Ophthalmol; 1991 Dec; 26(7):383-5. PubMed ID: 1764645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis.
    Halkiadakis I; Iliaki O; Kalyvianaki MI; Tsilimbaris MK
    Semin Ophthalmol; 2007; 22(1):55-7. PubMed ID: 17366121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting hypotropias following protective ptosis induced by botulinum neurotoxin.
    Heyworth PL; Lee JP
    Eye (Lond); 1994; 8 ( Pt 5)():511-5. PubMed ID: 7835443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
    Ghalamkarpour F; Aghazadeh Y; Odabaei G
    J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
    Sadiq SA; Dharmasena A
    Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.
    Fuchsluger T; Tuerkeli E; Westekemper H; Esser J; Steuhl KP; Meller D
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):955-64. PubMed ID: 17219124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
    Scheinfeld N
    Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to ramamurthi and rahman: induction of ptosis with botulinum toxin for thr treatment of recurrent corneal erosions.
    Bailey CS
    Eye (Lond); 2007 Aug; 21(8):1128. PubMed ID: 17571089
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
    Ellis MF; Daniell M
    Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral ptosis: a rare presentation.
    Farooq S; Dukht U; Jaffar S
    J Pak Med Assoc; 2009 May; 59(5):319-21. PubMed ID: 19438140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
    Reddy UP; Woodward JA
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apraclonidine in the treatment of ptosis.
    Wijemanne S; Vijayakumar D; Jankovic J
    J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.